BPC-157

Research context

BPC-157 is a synthetic 15-amino-acid pentadecapeptide derived from a partial sequence of body protection compound isolated from human gastric juice. In laboratory and preclinical animal studies it is investigated for its effects on angiogenesis, fibroblast migration, tendon-to-bone healing, gastrointestinal mucosal integrity, and nitric-oxide pathway modulation. The peptide is notable in the research literature for stability across a wide pH range, which distinguishes it from many neuropeptides that are rapidly degraded in gastric conditions. Research applications include tendon-healing models, colitis models, and vascular endothelial assays. Human clinical data remain limited; the peptide is unapproved by regulatory agencies and is supplied strictly for in-vitro and preclinical laboratory use.

Laboratory handling

Reconstitute with bacteriostatic water for laboratory handling. Avoid repeated freeze/thaw cycles of reconstituted material.

Storage & stability

Store lyophilized powder at -20°C, protected from light. Reconstituted solutions are stable at 2–8°C for up to 30 days when prepared in sterile bacteriostatic water.

Purity & testing standards

Each batch of BPC-157 is analyzed by an independent third-party laboratory. Standard release testing includes reverse-phase HPLC at 220 nm (purity target HPLC ≥99%), electrospray mass spectrometry (identity confirmation), and endotoxin screening. Batch numbers on each vial resolve to a downloadable COA on this site.

Recent COAs

FAQ